Future Tech Study finds GLP-1 diabetes drugs reduce risk of all types of substance use disorders by March 5, 2026 March 5, 2026 Read more
Future Tech Head-to-head trial shows Eli Lilly’s oral GLP-1 orforgaliprone outperforms oral semaglutide by February 27, 2026 February 27, 2026 Read more
Future Tech Why is the FDA banning compound GLP-1 drugs for weight loss? by February 19, 2026 February 19, 2026 Read more
Future Tech New GLP-1 weight loss drugs are coming – and they’re stronger than Wegovi and Zepbound by February 7, 2026 February 7, 2026 Read more
Future Tech Wegovi pill becomes first oral GLP-1 weight loss drug approved in the US by December 24, 2025 December 24, 2025 Read more
